tafoxiparin + oxytocin

**Tafoxiparin + oxytocin** is an investigational combination used in obstetric care, primarily studied for protracted or slow-progressing labor. **Tafoxiparin** is a synthetic, depolymerized form of heparin with negligible anticoagulant activity, developed to promote cervical ripening and enhance the labor process. **Oxytocin** is a well-established peptide hormone and uterotonic agent that induces uterine contractions. The combination is administered to augment uterine contractility and support cervical changes, aiming to reduce labor complications such as prolonged or arrested labor. Phase II clinical trials have shown that the combination may reduce labor time and improve cervical ripening, especially among women requiring induction or experiencing slow progression, though primary efficacy endpoints in larger studies were not met. The combination has demonstrated a favorable safety profile in mothers and infants.